Novacyt S.A.
ALNOV.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €35 | €44 | €77 | €260 |
| - Cash | €30 | €44 | €87 | €102 |
| + Debt | €12 | €14 | €1 | €2 |
| Enterprise Value | €17 | €13 | -€9 | €160 |
| Revenue | €20 | €12 | €21 | €96 |
| % Growth | 69.5% | -45% | -78% | – |
| Gross Profit | €32 | €4 | €6 | €30 |
| % Margin | 163.4% | 32.2% | 27.3% | 31% |
| EBITDA | -€34 | -€18 | -€12 | -€4 |
| % Margin | -174.8% | -157.6% | -55.5% | -4.4% |
| Net Income | -€42 | -€28 | -€22 | -€10 |
| % Margin | -212.7% | -244.3% | -105.5% | -10.2% |
| EPS Diluted | -0.59 | -0.4 | -0.31 | -0.14 |
| % Growth | -47.5% | -29% | -121.4% | – |
| Operating Cash Flow | -€9 | -€25 | -€14 | €16 |
| Capital Expenditures | -€2 | -€1 | -€0 | -€4 |
| Free Cash Flow | -€11 | -€26 | -€14 | €12 |